Membrane News and Research

RSS

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Scientists have uncovered the genomic signature to explain why 18F-FDG imaging performs better than PSMA-targeted imaging for prostate cancer patients with low or no expression of the prostate-specific membrane antigen (PSMA).

23 Jul 2020

Ultivue and OracleBio partner to help advance personalized tumor characterization and clinical oncology research using multiplex immunofluorescence

Ultivue and OracleBio partner to help further insights and advance personalized tumor characterization in translational and clinical oncology research.

From Ultivue 23 Jul 2020

siRNA-based treatment can reduce psoriasis symptoms

Psoriasis, a chronic skin condition that causes itchy, red, scaly patches, afflicts more than 8 million Americans and 125 million people worldwide.

23 Jul 2020

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

The cover for issue 29 of Oncotarget features, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model," by Lara, et al. which reported that adaptor proteins such as growth factor receptor-bound protein-2 play important roles in cancer cell signaling.

23 Jul 2020

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Researchers win grant to study why COVID-19 patients lose their sense of smell

Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.

22 Jul 2020

Study shows chloroquine does not prevent SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Scientists report two new cryo-EM structures representing the pre- and postfusion conformations of the full-length SARS-CoV-2 spike (S) protein, an essential viral component responsible for host cell entry and the spread of infection.

22 Jul 2020

Study captures unexpected features of SARS-Cov-2 spike protein

The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic.

22 Jul 2020

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

Detection and analysis of airborne coronavirus droplets using a bioengineered membrane is the focus of exploratory research at the University of Maine and University of Massachusetts Amherst, funded by the National Science Foundation.

21 Jul 2020

UVA earns international group's highest honor for quality heart and lung care

For its lifesaving care of patients with severely injured hearts and lungs, University of Virginia Medical Center has earned the Extracorporeal Life Support Organization's Platinum Level Center of Excellence Award, the international group's highest honor.

21 Jul 2020

RUB neuroscientists assess neuronal activity during stimulation-based learning process

Stimulating the fingertip rhythmically for a sustained period of time, markedly improves touch sensitivity of this finger. A research team led by Associate Professor Dr. Hubert Dinse at Ruhr-Universität Bochum analyzed the impact of this process in the brain.

21 Jul 2020

Advanced cryo-EM imaging reveals high-resolution structure of viral RNA replication complex

For the first time, scientists at the Morgridge Institute for Research have generated near atomic resolution images of a major viral protein complex responsible for replicating the RNA genome of a member of the positive-strand RNA viruses, the large class of viruses that includes coronaviruses and many other pathogens.

20 Jul 2020

McGill researchers discover bacterial organelles involved in gene expression

Researchers at McGill University have discovered bacterial organelles involved in gene expression, suggesting that bacteria may not be as simple as once thought.

20 Jul 2020

Australian researches detect SARS-CoV-2 virus in wastewater from planes and cruise ships

Previous reports have shown that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), has been found in untreated wastewater. While the data is limited, there are no reported cases of a person becoming infected with the virus due to exposure to contaminated water.

20 Jul 2020

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

A recent study published in the preprint server medRxiv in July 2020 shows that this is indeed possible. The development of this inexpensive but reliable and sensitive test could change the face of preventive measures for COVID-19 in low-resource settings.

17 Jul 2020

Common antioxidant enzyme catalase as COVID-19 treatment

A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.

17 Jul 2020

New insight into the SARS-CoV-2 infection process

Canadian researchers from the Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, have found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be using a unique method to gain entry into the cells.

16 Jul 2020

Study shows fused lung cells are pervasive in severe COVID-19

In a recent bioRxiv paper, scientists from Institut Pasteur and other research centers in France demonstrated how pathological effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are modulated by cellular proteins that can either inhibit or facilitate cell fusion and subsequent syncytia formation.

16 Jul 2020

Membrane News and Research

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Ultivue and OracleBio partner to help advance personalized tumor characterization and clinical oncology research using multiplex immunofluorescence

siRNA-based treatment can reduce psoriasis symptoms

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Researchers win grant to study why COVID-19 patients lose their sense of smell

Study shows chloroquine does not prevent SARS-CoV-2

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Study captures unexpected features of SARS-Cov-2 spike protein

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

UVA earns international group's highest honor for quality heart and lung care

RUB neuroscientists assess neuronal activity during stimulation-based learning process

Advanced cryo-EM imaging reveals high-resolution structure of viral RNA replication complex

McGill researchers discover bacterial organelles involved in gene expression

Australian researches detect SARS-CoV-2 virus in wastewater from planes and cruise ships

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Common antioxidant enzyme catalase as COVID-19 treatment

New insight into the SARS-CoV-2 infection process

Study shows fused lung cells are pervasive in severe COVID-19

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo